Celltrio
Fremont, US · 2 known investors
Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.
Founders & leadership
CD
Charlie DuncheonCEO & Cofounder
JK
Jin-Oh KimCTO & Cofounder
RK
Raphael KimVP, Software Engineering & Cofounder
JB
Jeff BairdChief Operations Officer
CC
Chau ChavezCFO
MK
Minbeom KimNamed on SEC filing
Investors · 2
Funding
SEC filings, press & company announcements$15M disclosed across 1 round · 2025
- $15MraisedJun 2025 · 4 sourcesSource ↗
▶$15MraisedJul 2025 · 1 investors · Other Health CareRule 506(b)
▶$15MraisedJul 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Minbeom KimDirector
- Jin-Oh KimDirector
- Raphael KimDirector
- Charlie DuncheonExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapMolecular Devices13 shared keywordsMolecular Devices develops laboratory instruments and automated workflows for life science research, including SpectraMax microplate readers, high-content screening and imaging systems, colony-picking devices, and 3D organoid and cell culture solutions. It serves researchers in drug discovery, cell line development, and screening, supported by AI-enabled analysis software and GxP compliance tools.
Cellares11 shared keywordsCellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies. The company serves biopharmaceutical manufacturers and cell therapy developers worldwide.
Cell Microsystems9 shared keywordsCell Microsystems develops automated instruments for cellular and molecular workflows used in life science research, including oncology, stem cell biology, and regenerative medicine. Its products support scientists in laboratory research and single-cell isolation and analysis.
Automata7 shared keywordsAutomata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.
Companies competing with Celltrio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Celltrio do?
- Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.
- Who founded Celltrio?
- Celltrio was founded by Charlie Duncheon, Jin-Oh Kim, Raphael Kim.
- Who are Celltrio's investors?
- Celltrio's investors include Asia2G Capital, Premier Partners.
- How much funding has Celltrio raised?
- Celltrio has disclosed $15M raised across 1 round.
- Where is Celltrio headquartered?
- Celltrio is headquartered in Fremont, US.